Skip to main content

Melasma

Research Abstract
Melasma is a common aesthetic problem characterized by facial hyperpigmentation. It frequently affects young to middle-aged females who are Hispanic or of Asian, African or Middle Eastern descent. Its pathogenesis is still mysterious with multiple factors are being accused to play a role. Although many treatment options are currently available, melasma is difficult to cure with tendency to relapse. Melasma (a term derived from the Greek word “melas” meaning black) is a worldwide prevalent acquired disorder of hyperpigmentation that commonly affects females with Fitzpatrick skin phototypes III-V (Goh and Dlova, 1999 and Gupta et al., 2006). It is characterized by appearance of symmetrical light to dark brown spots and patches on sun exposed areas mostly the face and especially the forehead, cheeks and chin (Kang and Ortonne, 2009). Melasma is sometimes termed chloasma (derived from the Greek word “chloas” meaning green) or mask of pregnancy when it develops in pregnant females (Handel et al., 2014a).
Research Authors
Eman R. M. Hofny, Amira A. Abdel-Motaleb, Alaa Ghazally, Asmaa Mahmoud Ahmed, Mahmoud R. Hussein,
Research Department
Research Journal
Archives of Biological and Biomedical Research
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
Vol.1, No.1
Research Website
NULL
Research Year
2017

Melasma

Research Abstract
Melasma is a common aesthetic problem characterized by facial hyperpigmentation. It frequently affects young to middle-aged females who are Hispanic or of Asian, African or Middle Eastern descent. Its pathogenesis is still mysterious with multiple factors are being accused to play a role. Although many treatment options are currently available, melasma is difficult to cure with tendency to relapse. Melasma (a term derived from the Greek word “melas” meaning black) is a worldwide prevalent acquired disorder of hyperpigmentation that commonly affects females with Fitzpatrick skin phototypes III-V (Goh and Dlova, 1999 and Gupta et al., 2006). It is characterized by appearance of symmetrical light to dark brown spots and patches on sun exposed areas mostly the face and especially the forehead, cheeks and chin (Kang and Ortonne, 2009). Melasma is sometimes termed chloasma (derived from the Greek word “chloas” meaning green) or mask of pregnancy when it develops in pregnant females (Handel et al., 2014a).
Research Authors
Eman R. M. Hofny, Amira A. Abdel-Motaleb, Alaa Ghazally, Asmaa Mahmoud Ahmed, Mahmoud R. Hussein,
Research Department
Research Journal
Archives of Biological and Biomedical Research
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
Vol.1, No.1
Research Website
NULL
Research Year
2017

Thymoquinone, but Not Metformin, Protects against Gentamicin-Induced Nephrotoxicity and Renal Dysfunction in Rats

Research Abstract

Background: Gentamicin (GM) is an antibiotic that is widely used to treat many Gram-negative bacteria, such as those involved in urinary tract infections. However, being nephrotoxic, GM dose adjustment and reno-protective elements must be concurrently administered with GM to minimize kidney damage. Oxidative stress plays a pivotal role in the pathogenesis of GM-induced nephrotoxicity. Thymoquinone (TQ) is a promising therapeutic substance, that is being extensively studied in many diseases, such as diabetes mellitus, cancer, hypertension, and others. The powerful antioxidant properties of TQ may greatly help in minimizing GM nephrotoxicity. Metformin (MF) is a well-known, clinically approved oral hypoglycaemic drug that has many other actions, including antioxidant properties. The aim of this work was to evaluate the possible antioxidant and reno-protective effects of TQ and metformin in GM-induced nephrotoxicity in the same model (rats) at the same time. In addition, we aimed to further understand the effects underlying GM-induced nephrotoxicity. Methods: Twenty male rats were randomly divided into four equal groups: the first group (control) received distilled water; the second group received GM only; the third group received concurrent oral TQ and GM; and the fourth group received concurrent oral MF and GM. After 4 weeks, renal function and histopathology, as well as levels of the oxidative markers glutathione peroxidase-1 (GLPX1), superoxide dismutase (SOD), and malondialdehyde (MDA) in the kidney tissues, were assessed. Results: Compared with the control group, and as expected, the GM-injected rats showed significant biochemical and histological changes denoting renal damage. Compared with GM-injected rats, the concurrent administration of TQ with GM significantly reduced the levels of serum creatinine, serum urea, and tissue MDA and significantly increased the levels of GLPX1 and SOD. Concurrent metformin administration with GM significantly increased the levels of both GLPX1 and SOD and significantly decreased the levels of tissue MDA but had no significant effect on serum creatinine and urea levels. Compared with GM-injected rats, the addition of either TQ or MF resulted in a reduction in endothelial proliferation and mesangial hypercellularity. Conclusions: Both TQ and MF effectively alleviated the oxidative stress in GM-induced nephrotoxicity in rats, with TQ but not MF producing a complete reno-protective effect. Further studies for evaluation of different reno-protective mechanisms of TQ should be conducted.

Research Authors
Mansour Alsharidah 1,*OrcID,Abdel-Moneim Hafez Abdel-Moneim 1,2OrcID,Ashwag Saleh Alsharidah,Mugahid A. Mobark ,Arshad Husain Rahmani, Ahmed Shata ,Ahmed A. H. Abdellatif ,Mahmoud Zaki El-Readi ,Khalid M. Mohany and
Research Date
Research Department
Research Journal
applied Sciences
Research Pages
3981
Research Publisher
MDPI
Research Vol
11(9)
Research Website
NULL
Research Year
2021


55.
Prevalence of gastroesophageal reflux disease in patients with laryngeal and voice disorders

Research Abstract
NULL
Research Authors
Makhadoom N, Abouloyoun A, Bokhary HA, Dhafar KO, Gazzaz ZJ, Azab BA.
Saudi Med J. 2007 Jul;28(7):1068-71
Research Journal
Saudi Med J. 2007 Jul;28(7):1068-71.
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2007

Treatment of Chronic Back Pain with Radiculopathy by Selective Nerve Root Block or Pulsed Radiofrequency - Randomised, Open Label, Clinical Trial

Research Abstract
NULL
Research Authors
Ali A*, Osman AM, Rada M, and Bakr MA
Research Journal
Journal of Anesthesia and Patient CareObjective
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Treatment of Chronic Back Pain with Radiculopathy by Selective Nerve Root Block or Pulsed Radiofrequency - Randomised, Open Label, Clinical Trial

Research Abstract
NULL
Research Authors
Ali A*, Osman AM, Rada M, and Bakr MA
Research Journal
Journal of Anesthesia and Patient CareObjective
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Treatment of Chronic Back Pain with Radiculopathy by Selective Nerve Root Block or Pulsed Radiofrequency - Randomised, Open Label, Clinical Trial

Research Abstract
NULL
Research Authors
Ali A*, Osman AM, Rada M, and Bakr MA
Research Journal
Journal of Anesthesia and Patient CareObjective
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Treatment of Chronic Back Pain with Radiculopathy by Selective Nerve Root Block or Pulsed Radiofrequency - Randomised, Open Label, Clinical Trial

Research Abstract
NULL
Research Authors
Ali A*, Osman AM, Rada M, and Bakr MA
Research Journal
Journal of Anesthesia and Patient CareObjective
Research Member
Research Pages
NULL
Research Publisher
NULL
Research Rank
1
Research Vol
NULL
Research Website
NULL
Research Year
2017

Successful Management of Functional Aphonia Using a Modified Voice Therapy Technique; A Case Series Study

Research Abstract
NULL
Research Authors
Aboloyoun I.Alia,e , Marglani Osamac, Elmorsy A.Sohab,d, ElKholy M.Rashae, Farooq U.Mianf
Research Journal
The paper is accepted for publication in The Egyptian Journal of Otolaryngology on May 22, 2017:
Research Pages
NULL
Research Publisher
NULL
Research Rank
2
Research Vol
NULL
Research Website
NULL
Research Year
2017
Subscribe to